Stock listing

Cipher Pharmaceuticals Inc.

Selected listing: PHE · FWB · EUR · DE

Cipher Pharmaceuticals Inc. (Frankfurt:PHE), Health Technology. Latest release Sep 21, 2026: Cipher Pharmaceuticals Announces the Appointment of Rajiv De…

PHE:FWBEURDEUpdated October 2, 2026

Ticker: Frankfurt:PHE
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Other
Exchange: Frankfurt
Currency: EUR

Latest news from Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Announces the Appointment of Rajiv De Silva to its Board of Directors

September 21, 2026

Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award

September 1, 2026

Cipher Pharmaceuticals Reports Second Quarter 2026 Results

August 11, 2026

Cipher Pharmaceuticals Schedules Q2 2026 Earnings Release and Conference Call

July 31, 2026

Cipher Pharmaceuticals and the pan-Canadian Pharmaceutical Alliance (pCPA) Sign Letter of Intent for Public Drug Plan Coverage of Epuris®

July 6, 2026

All Cipher Pharmaceuticals Inc. news →

Events

Replays

Cipher Pharmaceuticals Inc. (CPH) Q2 2026 Earnings Call
Wed, Aug 12, 2026 · 08:30 AM ET
Watch
Cipher Pharmaceuticals Inc. (CPH) Q1 2026 Earnings Call
Fri, May 08, 2026 · 08:30 AM ET
Watch
Cipher Pharmaceuticals Inc. (CPH) Q4 2025 Earnings Call
Fri, Mar 13, 2026 · 08:30 AM ET
Watch

Research Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Inc. company profile

View the public company page for Cipher Pharmaceuticals Inc. on 6ix.

Cipher Pharmaceuticals Inc. news

Read company news and market updates connected to Cipher Pharmaceuticals Inc..

Cipher Pharmaceuticals Inc. investor events

Find investor webinars, events, and replay context for Cipher Pharmaceuticals Inc..